Thursday, 7 June 2018 AusCann Group Holdings Ltd (ASX:AC8) has completed its second harvest with DayaCann joint venture partner Fundación Daya in Chile. AusCann’s managing director Elaine Darby: “This second harvest in Chile represents an important step in our Chilean operation. “It is encouraging to see that our medical cannabis can be accessed by patients through the new SAS scheme in Chile whilst clinical studies are progressing.” READ: AusCann Group gets regulatory nod to supply medicinal cannabis products in Chile Fundación Daya has worked with the Chilean National Institute of Public Health to establish a special access scheme (SAS) which enables patients in Chile access to local medicinal cannabis product. The medical cannabis product in Chile’s SAS is being locally manufactured at Knop Laboratories from cannabis supplied by DayaCann. Harvest yielded over 50% more than first crop The second crop yielded 620 kilograms of dried cannabis product, an increase of over 50% on the 400 kilograms yielded from the first crop. This equates to a yield of about 1.2 tonnes per hectare. First-mover following legislative change AusCann sees the South American market as internationally significant following recent legislative changes in Argentina, which has joined Chile, Colombia and Uruguay in legalising medical cannabis for therapeutic purposes.
According to Reuters, healthcare shares on Wall Street were trading lower at the closing bell for a second day. On April 17th, United Health Group, Merck & Co., Pfizer, and Abbott Laboratories end the..
The Akron-Canton Regional Foodbank, the Greater Cleveland Food Bank, Second Harvest Food Bank of the Mahoning Valley and the Second Harvest Food Bank of North Central Ohio are collaborating to host the..